Jiang and colleagues21 have recently shown that inhibition of FAK sensitizes tumors to chemotherapy and immune checkpoint inhibitor by reducing immunosuppressive cells [MDSCs, tumor associated macrophages (TAM), T reg] and consequently impacting effector T cell infiltration into the TME of PDAC KPC mouse models. The gene discussed is PTK2; the disease is neoplasm.